Latest Roswell Park Cancer Institute Stories
New updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Ovarian Cancer were presented at the NCCN 14th Annual Conference on March 14.
A roundtable led by Clifford Goodman, PhD, at the NCCN 14th Annual Conference, presented various views on "Finding and Achieving Value in Cancer Care." The panel of experts tackled the spectrum of issues related to defining value, and the concern that the benefit to patients of some of the latest cancer treatments may not warrant their costs.
New updates to the NCCN Guidelines for Pancreatic Adenocarcinoma were announced on March 12 at the NCCN 14th Annual Conference.
Minimally-invasive oncologic surgery procedures can be beneficial, but physicians need to be prudent when recommending the option to their patient according to Thomas A. D'Amico, MD, of Duke Comprehensive Cancer Center. Dr.
A roundtable dedicated to cancer survivorship at the NCCN 14th Annual Conference highlighted the need for transition care plans and improved physician/patient communication for cancer survivors.
NCCN announces new modifications to the NCCN Guidelines for Colon and Rectal Cancers.
Updated guidelines for physicians that represent best practices for using magnetic resonance imaging (MRI) to newly diagnose breast cancer and to make treatment decisions for breast cancer were published today in the Journal of the National Comprehensive Cancer Network.
NCCN names Cold Spring Publishing, LLC, as the new publishing company for JNCCN - The Journal of the National Comprehensive Cancer Network. Cold Spring Publishing is a newly formed medical publishing company led by Jack Gentile, founder of PRR, Inc., and Conor Lynch.
NCCN announces new updates to the NCCN Guidelines for Breast Cancer and Breast Cancer Risk Reduction Guidelines.
NCCN recently received a $4 million research grant from Wyeth Pharmaceuticals to evaluate the safety and effectiveness of temsirolimus in the treatment of solid tumors. Temsirolimus is currently approved to treat advanced renal cell carcinoma (RCC).
- A poem in which the author retracts something said in an earlier poem.